Showing results filtered by:
92 Results
Achievements of the NIAID Division of Microbiology and Infectious Diseases in the prevention, diagnosis, and treatment of infectious diseases.
Last Reviewed: May 13, 2022
NIAID Organizational Chart
https://www.niaid.nih.gov/sites/default/files/NIAID-Organizational-Chart.pdf
The 189 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened at 10:30 a.m. on Monday, June 4, 2018, in Conference Rooms E1/E2, Building 45, National Institutes of Health. Dr. Anthony S. Fauci, director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was
Last Reviewed: September 11, 2018
Wiskott Aldrich Syndrome (WAS) Factsheet
https://www.niaid.nih.gov/sites/default/files/Wiskott-Aldrich-Syndrome-Factsheet.pdf
Last Reviewed: November 30, 2017
We seek to develop methods and strategies to identify individuals with, or at high risk of, developing severe allergic inflammation and anaphylaxis in order to identify specific pathways leading to these phenotypes and enable the development of new therapies that can successfully limit and/or prevent these potentially devastating consequences.
Last Reviewed: October 6, 2022
The Clinical Parasitology Unit is an interdisciplinary group of clinically trained LPD staff members who oversee the clinical research portfolio and provide clinical care, consultations, and training in tropical medicine and parasitology.
Last Reviewed: November 21, 2022
Meet the fellows in the 2020 Intramural NIAID Research Opportunities (INRO)! INRO is an initiative to promote biomedical research training in populations underrepresented in the biomedical sciences and those dedicated to promoting diversity and inclusion.
Last Reviewed: March 3, 2023
NIAID Biodefense Research Agenda for CDC Category A Agents - February 2002
https://www.niaid.nih.gov/sites/default/files/biotresearchagenda.pdf
Last Reviewed: August 6, 2019
Table 1: Scoring System with Clinical and Laboratory Tests for Individuals in Kindreds with HIES
https://www.niaid.nih.gov/sites/default/files/scoringsystem.pdf
Last Reviewed: August 6, 2019
Resources about some of the forms of primary immune deficiency diseases (PIDDs) which NIAID is currently studying.
Last Reviewed: September 13, 2019
The 190 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened at 10:30 a.m. on Monday, September 17, 2018, in Conference Rooms E1/E2, Building 45, National Institutes of Health. Dr. Anthony S. Fauci, director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting
Last Reviewed: January 14, 2019
The 201 st meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Monday, June 6, 2022. Dr. Anthony S. Fauci, Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 12:02 p.m. and from 1:00 p
Last Reviewed: September 7, 2022
The 188 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened at 10:30 a.m. on Monday, January 29, 2018, in Conference Rooms E1/E2, Building 45, National Institutes of Health. Dr. Anthony S. Fauci, director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was
Last Reviewed: May 16, 2018
Opportunistic fungal infections represent major causes of morbidity and mortality despite the administration of antifungal therapy. A better mechanistic understanding of host-fungal interactions will inform the development of improved immune-based strategies for the prevention, risk stratification, prognostication, vaccination, and treatment of vulnerable patient populations. In the Fungal
Last Reviewed: December 12, 2023
INRO is an initiative to promote biomedical research training in populations underrepresented in the biomedical sciences and those dedicated to promoting diversity and inclusion. Read about the unique experiences of the participants that led them to pursue postbac research training at NIAID.
Last Reviewed: October 10, 2023
The 205 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened at 5601 Fishers Lane in the Grand Hall at 10:30 a.m. on Monday, September 11, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public
Last Reviewed: January 11, 2024
The 200 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Monday, January 31, 2022. Dr. Anthony S. Fauci, director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:38 a.m. and from 1
Last Reviewed: May 27, 2022